Free-Market Republicans Turn on Mylan, Say EpiPen Went Too Far


At a brutal congressional hearing in Washington Wednesday, Mylan NV didn't have any friends among Republicans who said they wished they could defend the drugmaker. Republicans who described themselves as "free market" and "pro-business" said that the drugmaker's aggressive pricing of its EpiPen allergy shot -- the cost of which went up about sixfold since Mylan acquired it in 2007 -- had gone too far.



from Biotech News